Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Verona Pharma PLC ADR
I9SACurrent price
33.4 EUR
-0.6 EUR (-1.76%)
Last closed
35.37 USD
Company
www.veronapharma.com
ISIN
US9250501064
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
3 157 047 808 USD
Yield for 12 month
+145.09 %
1Y
3Y
5Y
10Y
15Y
I9SA
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Address: 3 More London Riverside, London, United Kingdom, SE1 2RE
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
45.81 USDP/E ratio
–Dividend Yield
–Current Year
+458 000 USD
Last Year
+458 000 USD
Current Quarter
+5 624 000 USD
Last Quarter
–
Current Year
-679 624 USD
Last Year
+112 000 USD
Current Quarter
+5 081 000 USD
Last Quarter
-270 302 USD
Key Figures I9SA
1 year
3 years
5 years
10 years
EBITDA
-150 286 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.83 %
PEG Ratio
–
Return On Equity TTM
-56.85 %
Wall Street Target Price
45.81 USD
Revenue TTM
5 624 000 USD
Book Value
2.08 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
112 000 USD
Earnings per share
-2 USD
Diluted Eps TTM
-2 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics I9SA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History I9SA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation I9SA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
523.3493
Price Sales TTM
561.3527
Enterprise Value EBITDA
-20.8947
Price Book MRQ
24.1936
Financials I9SA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators I9SA
For 52 weeks
11.39 USD
40.02 USD
50 Day MA
31.75 USD
Shares Short Prior Month
8 011 882
200 Day MA
21.12 USD
Short Ratio
8.71
Shares Short
7 943 446
Short Percent
10.14 %
BeatStart